Substance,Type of TRV,TRV Value,Study Details,"Threshold/
Non-threshold
Endpoint",TRV Derivation Method,"Critical
Effect(s)","Carcinogenicity
Classification",Source
n-Hexane,"Oral TDI
(provisional)","1.0E-01
mg/kg -day
BW","Study Type: subchronic
Species: rats
Mode of Administration: gavage
Exposure Regime: 0, 66, 132, or
264 mg/day, 7 days/week
Duration: 4 weeks
Uncertainty Factors: 90 (10 for
intraspecies variability, 3 for interspecies
variability, and 3 for deficiencies in
the database)","POD = 8 mg/kg -day
BW",TDI = POD/UF,"Neurotoxicity
(motor nerve
conduction
velocity, mixed
nerve conduction
velocity)","CEPA:
not assessed
IARC:
not classified
US EPA IRIS:
inadequate
information to
assess carcinogenic
potential (US EPA,
2005b)","CCME, 2011
(based on EEI,
2008 [derived
from Ono et al.,
1979, 1981])"
n-Hexane,"Inhalation TC
(provisional)","7.0E-01
mg/m3","Study Type: subchronic
Species: Wistar male rats
Mode of Administration: inhalation
(whole body exposure chambers)
Exposure Regime: 0, 500, 1200, or
3000 ppm nhexane vapour (0, 1762,
4230, or 10 574 mg/m3), 12 hours/day,
7 days/week
Duration: 16 weeks
Uncertainty Factors: 300 (10 for
intraspecies variability, 3 for interspecies
variability, 3 for use of a subchronic study,
and 3 for database deficiencies)","BMCL = 122 ppm
(430 mg/m3)","BMCL adjusted for
continuous exposure
BMCL = 215 mg/m3
HEC
TC = BMCL /UF
HEC","Neurotoxicity
(peripheral
neuropathy –
decreased motor
nerve conduction
velocity)",,"US EPA, 2005b
(based on
Huang et al.,
1989)"
Lead1,"Risk-specifci dose
(provisional)","5.0E-04
mg/kg -day
BW","Study Type: epidemiological
(meta-analysis)
Species: humans
Mode of Exposure: N/A
Exposure Concentrations: N/A
Duration: from birth or infancy until 5
to 10 years of age
Uncertainty Factors: none","BMDL =
01
0.5 µg/kg -day
BW","95th lower confidence limit
of the BMD associated with
a 1 IQ point decrement
(intake rate associated with
a drop of 1 IQ point in a
population of children)
Risk-specific dose = BMDL
01
(no adjustment)","Neuro-
developmental
toxicity
(cognitive function)","CEPA:
not classified
IARC: Group 2A
probably
carcinogenic
to humans
(IARC, 2006)
US EPA IRIS:
Group B2
probable human
carcinogen
(US EPA, 1988b)","EFSA, 2013
(based on
Lanphear et al.,
2005)"
